Moritz, J.; Schwab, A.; Reinisch, A.; Zebisch, A.; Sill, H.; Wölfler, A.
Measurable Residual Disease Detection in Acute Myeloid Leukemia: Current Challenges and Future Directions. Biomedicines 2024, 12, 599.
https://doi.org/10.3390/biomedicines12030599
AMA Style
Moritz J, Schwab A, Reinisch A, Zebisch A, Sill H, Wölfler A.
Measurable Residual Disease Detection in Acute Myeloid Leukemia: Current Challenges and Future Directions. Biomedicines. 2024; 12(3):599.
https://doi.org/10.3390/biomedicines12030599
Chicago/Turabian Style
Moritz, Jennifer, Antonia Schwab, Andreas Reinisch, Armin Zebisch, Heinz Sill, and Albert Wölfler.
2024. "Measurable Residual Disease Detection in Acute Myeloid Leukemia: Current Challenges and Future Directions" Biomedicines 12, no. 3: 599.
https://doi.org/10.3390/biomedicines12030599
APA Style
Moritz, J., Schwab, A., Reinisch, A., Zebisch, A., Sill, H., & Wölfler, A.
(2024). Measurable Residual Disease Detection in Acute Myeloid Leukemia: Current Challenges and Future Directions. Biomedicines, 12(3), 599.
https://doi.org/10.3390/biomedicines12030599